Supernus Pharmaceuticals, Inc. (SUPN) Balance Sheet
As of 2026-06-30 (10-Q), Supernus Pharmaceuticals, Inc. (SUPN) reported total assets of $1.4B, total liabilities of $396.9M and shareholders' equity of $1.0B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $180.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SUPNSupernus Pharmaceuticals, Inc.Follow SUPN — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.04 | 0.03 | 0.04 | 0.03 | 0.07 | 0.10 | 0.19 | 0.18 | 0.29 | 0.20 | 0.09 | 0.07 | 0.13 | 0.18 | |
| Short-term investments | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | 0.04 | 0.16 | 0.17 | 0.13 | 0.14 | 0.37 | — | — | — | |
| Receivables | 0.00 | 0.01 | 0.02 | 0.03 | 0.04 | 0.07 | 0.10 | 0.09 | 0.14 | 0.15 | 0.17 | 0.14 | 0.19 | 0.21 | |
| Inventory | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.09 | 0.09 | 0.05 | 0.11 | 0.11 | |
| Current assets | 0.09 | 0.10 | 0.11 | 0.11 | 0.15 | 0.23 | 0.49 | 0.47 | 0.63 | 0.60 | 0.73 | 0.69 | 0.64 | 0.72 | |
| Total assets | 0.09 | 0.11 | 0.14 | 0.19 | 0.31 | 0.42 | 0.98 | 1.16 | 1.50 | 1.69 | 1.70 | 1.37 | 1.45 | 1.43 | |
| Current liabilities | 0.02 | 0.03 | 0.03 | 0.06 | 0.08 | 0.12 | 0.16 | 0.16 | 0.25 | 0.32 | 0.69 | 0.29 | 0.34 | 0.35 | |
| Long-term debt | 0.02 | — | — | — | — | — | — | — | — | 0.38 | — | — | — | — | |
| Short-term debt | — | — | — | — | — | — | — | — | — | 0.00 | 0.40 | — | — | — | |
| Total liabilities | 0.04 | 0.08 | 0.10 | 0.10 | 0.12 | 0.16 | 0.52 | 0.56 | 0.76 | 0.87 | 0.82 | 0.33 | 0.39 | 0.40 | |
| Shareholders' equity | 0.06 | 0.03 | 0.04 | 0.09 | 0.19 | 0.27 | 0.45 | 0.60 | 0.74 | 0.82 | 0.89 | 1.04 | 1.06 | 1.03 |
USD billions · SEC XBRL
Supernus Pharmaceuticals, Inc. — questions
- How much cash does Supernus Pharmaceuticals, Inc. have?
- $180.0M in cash and cash equivalents as of 2026-06-30.
- What are Supernus Pharmaceuticals, Inc.'s total assets?
- $1.4B as of 2026-06-30.
- What is Supernus Pharmaceuticals, Inc.'s shareholders' equity?
- $1.0B as of 2026-06-30.
Every figure on this page comes from Supernus Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.